What are the dosing recommendations and prescribing guidelines for Yaz (drospirenone 3 mg/ethinyl estradiol 0.02 mg), including contraindications and missed‑tablet management?

Yaz Dosing Recommendations and Prescribing

Yaz (drospirenone 3 mg/ethinyl estradiol 0.02 mg) should be taken as one light pink tablet daily for 24 consecutive days, followed by one white inert tablet daily for 4 days, with initiation ideally within the first 5 days of menstrual bleeding to avoid the need for backup contraception. 1

Formulation and Regimen

• Yaz contains 24 light pink active tablets (each with 3 mg drospirenone and 0.02 mg ethinyl estradiol) followed by 4 white inert tablets in a 28-day blister pack. 1

• The 24/4 regimen (24 active days, 4 hormone-free days) provides a shorter hormone-free interval compared to traditional 21/7 oral contraceptives, which may enhance ovarian suppression and contraceptive effectiveness. 2, 3

• Withdrawal bleeding typically occurs within 3 days of starting the white tablets. 1

Initiation Timing and Backup Contraception

• Start Yaz on any day if reasonably certain the patient is not pregnant (same-day initiation is recommended). 1

• No backup contraception is needed if Yaz is started within the first 5 days of menstrual bleeding. 2

• If started >5 days after menstrual bleeding begins, use backup contraception (e.g., condoms) or abstain from intercourse for 7 consecutive days of active pill use. 2, 1

• When switching from another combined oral contraceptive, start Yaz on the same day a new pack of the previous pill would have been started (no backup needed). 1

• When switching from patch, ring, injection, IUD, or implant: Start Yaz when the next application/dose would be due or on the day of device removal; use backup contraception for 7 days. 1

Postpartum and Post-Abortion Initiation

• For non-breastfeeding postpartum women or after second-trimester abortion, start Yaz no earlier than 4 weeks postpartum due to increased thromboembolism risk. 1

• If starting postpartum before the first period, evaluate for pregnancy and use backup contraception for 7 consecutive days. 1

Missed Tablet Management

One Tablet Late (<24 hours)

• Take the late tablet as soon as possible; continue the remaining tablets at the usual time (even if taking two pills the same day). 4
• No backup contraception needed. 4
• Emergency contraception is not usually needed but can be considered if pills were missed earlier in the cycle or in the last week of the previous cycle. 4

One Tablet Missed (24 to <48 hours)

• Take the most recent missed tablet immediately (discard any other missed tablets). 4
• Continue remaining tablets at the usual time (even if taking two pills the same day). 4
• No backup contraception needed. 4
• Emergency contraception is not usually needed but can be considered if appropriate. 4

Two or More Consecutive Tablets Missed (≥48 hours)

• Take the most recent missed tablet immediately (discard other missed tablets). 4
• Continue remaining tablets at the usual time. 4
• Use backup contraception (e.g., condoms) or abstain from intercourse until active tablets have been taken for 7 consecutive days. 4

If pills were missed in the last week of active tablets (days 15-24):

• Omit the hormone-free interval by finishing the active tablets in the current pack and starting a new pack the next day. 4
• If unable to start a new pack immediately, use backup contraception or abstain until active tablets from a new pack have been taken for 7 consecutive days. 4

If pills were missed during the first week and unprotected intercourse occurred in the previous 5 days:

• Consider emergency contraception. 4

Missed White (Inert) Tablets

• Discard the missed white tablet(s) and continue taking tablets to maintain the schedule. 1
• The patient remains protected against pregnancy if she begins the next cycle of light pink tablets on the proper day. 1

Gastrointestinal Disturbances

Vomiting or Diarrhea <24 Hours After Taking a Tablet

• No need to redose; continue taking pills daily at the usual time. 4
• No additional contraceptive protection needed. 4

Vomiting or Diarrhea Continuing 24 to <48 Hours

• Continue taking pills daily at the usual time. 4
• Use backup contraception or abstain until active pills have been taken for 7 consecutive days after symptoms resolve. 4
• If vomiting/diarrhea occurred in the last week of active pills (days 15-24), omit the hormone-free interval by starting a new pack immediately. 4
• Consider emergency contraception if symptoms occurred in the first week and unprotected intercourse occurred in the previous 5 days. 4

Vomiting or Diarrhea Continuing ≥48 Hours

• Follow the same instructions as for 24 to <48 hours of symptoms. 4
• Use backup contraception or abstain until 7 consecutive days of active pills after symptom resolution. 4

Severe Vomiting Within 3-4 Hours of Taking a Tablet

• Regard this as a missed tablet and follow missed-pill instructions accordingly. 1

Absolute Contraindications

Do not prescribe Yaz to women with: 1

• Renal impairment (drospirenone has antimineralocorticoid activity and may increase potassium)
• Adrenal insufficiency
• High risk of arterial or venous thrombotic disease, including:
  • Smoking if over age 35
  • Current or past deep vein thrombosis or pulmonary embolism
  • Cerebrovascular disease
  • Coronary artery disease
  • Thrombogenic valvular or rhythm diseases (e.g., atrial fibrillation, subacute bacterial endocarditis)
  • Inherited or acquired hypercoagulopathies
  • Uncontrolled hypertension
  • Diabetes mellitus with vascular disease
  • Migraine headaches with or without aura if over age 35, or migraine with focal neurological symptoms at any age
• Undiagnosed abnormal uterine bleeding
• Current or past breast cancer or other estrogen- or progestin-sensitive cancer
• Liver tumors (benign or malignant) or liver disease
• Pregnancy (no reason to use during pregnancy)

Key Warnings and Precautions

• Thromboembolism risk is highest during the first year of use, particularly in the first 6 months, and when restarting after a ≥4-week pill-free interval. 1

• Stop Yaz immediately if an arterial or venous thrombotic event occurs. 1

• The risk of venous thromboembolism with combined oral contraceptives is 3 to 9 per 10,000 woman-years, but pregnancy itself increases VTE risk as much or more. 1

• Drospirenone's antimineralocorticoid activity distinguishes it from other progestins; monitor potassium in patients at risk for hyperkalemia (renal/hepatic/adrenal disease, concurrent use of potassium-sparing drugs). 3, 5

Clinical Pearls and Common Pitfalls

• The 24/4 regimen provides a shorter hormone-free interval than traditional 21/7 pills, which may reduce follicular activity and improve contraceptive reliability, especially for women who miss pills. 4, 2, 3

• Lower-dose ethinyl estradiol formulations (20 μg) show more follicular activity when doses are missed compared to 30-35 μg formulations, making adherence counseling critical. 4, 2

• Yaz has three FDA-approved indications: contraception, treatment of premenstrual dysphoric disorder (PMDD) in women who choose oral contraception, and treatment of moderate acne vulgaris in women ≥14 years who desire oral contraception. 1, 6, 5

• Breakthrough bleeding or spotting is common in the first few cycles (14.9% in cycle 1, decreasing to 5.5% by cycle 6) and usually resolves without intervention; reassure patients to continue taking pills. 1, 7

• Women who frequently miss pills should be counseled to consider long-acting reversible contraception (IUD, implant, or injectable) that is less user-dependent. 4

• Contraceptive efficacy is excellent with typical use (Pearl Index 0.3-0.41), comparable to other modern combined oral contraceptives. 6, 8, 7